# OSCR (Oscar Health, Inc.) - SEC EDGAR Financial Statements

> Oscar Health, Inc. reported $17.47B in revenue and net income of $855.5M for the trailing twelve months ended September 30, 2026 (up 72.1% year over year), with a 5.4% operating margin.

- Canonical: https://convexityos.com/fundamentals/OSCR
- Markdown: https://convexityos.com/fundamentals/OSCR.md
- SEC CIK: 0001568651
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:10 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001568651&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $17.47B | +72.1% YoY |
| Operating Income | TTM | $937.0M | 5.4% margin |
| Net Income | TTM | $855.5M | 4.9% net margin |
| Diluted EPS | TTM | $2.47 | Split-adjusted |
| Free Cash Flow | TTM | $4.14B | 23.7% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $7.49B | Total debt: $432.4M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $11.70B | $9.18B | $5.86B | $3.96B | $1.84B | $462.8M | $488.2M |
| Selling, General & Admin | $2.05B | $1.76B | $1.43B | $1.26B | -- | -- | -- |
| **Operating Income** | -$396.4M | $57.27M | -$235.6M | -$589.9M | -$544.5M | -$402.3M | -$259.4M |
| **EBITDA** | -$367.5M | $89.41M | -$204.9M | -$574.6M | -$529.9M | -$391.0M | -$252.5M |
| Interest Expense | $17.60M | $23.73M | $24.60M | $22.62M | $4.72M | $3.51M | $0 |
| Income Before Tax | -$437.3M | $33.43M | -$267.3M | -$610.1M | -$570.6M | -$405.8M | -$259.4M |
| Income Tax Expense | $5.61M | $7.30M | $3.29M | -$523K | $846K | $1.04M | $1.79M |
| **Net Income** | -$443.2M | $25.43M | -$270.7M | -$606.3M | -$572.6M | -$406.8M | -$261.2M |
| Basic EPS | -$1.69 | $0.11 | -$1.22 | -$2.85 | -$3.20 | -$14.16 | -$9.06 |
| **Diluted EPS** | -$1.69 | $0.10 | -$1.22 | -$2.85 | -$3.20 | -$14.16 | -$9.06 |
| Basic Shares Outstanding | 262.4M | 240.4M | 221.7M | 212.5M | 179.0M | 29.3M | 28.8M |
| Diluted Shares Outstanding | 262.4M | 265.9M | 221.7M | 212.5M | 179.0M | 29.3M | 28.8M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $5.14B | $4.88B | $4.65B | $2.81B | $2.99B | $2.86B | $3.05B | $2.39B |
| Selling, General & Admin | $721.9M | $691.1M | $706.2M | $511.0M | $521.6M | $534.5M | $482.8M | $465.8M |
| **Operating Income** | $178.0M | $388.6M | $704.1M | -$333.7M | -$129.2M | -$230.5M | $297.1M | -$147.7M |
| **EBITDA** | $184.6M | $394.7M | $711.1M | -$325.9M | -$121.9M | -$223.5M | $303.9M | -$138.5M |
| Interest Expense | $4.73M | $4.71M | $5.38M | -$1.10M | $6.86M | $5.85M | $5.99M | $6.03M |
| Income Before Tax | $175.4M | $383.0M | $698.8M | -$352.7M | -$139.3M | -$233.5M | $288.2M | -$153.7M |
| Income Tax Expense | $8.08M | $21.18M | $19.75M | -$247K | -$1.81M | -$5.04M | $12.71M | -$404K |
| **Net Income** | $167.3M | $361.8M | $679.0M | -$352.6M | -$137.4M | -$228.4M | $275.3M | -$153.5M |
| Basic EPS | $0.54 | $1.20 | $2.28 | -- | -$0.53 | -$0.89 | $1.10 | -- |
| **Diluted EPS** | $0.49 | $1.10 | $2.07 | -- | -$0.53 | -$0.89 | $0.92 | -- |
| Basic Shares Outstanding | 309.3M | 302.2M | 298.2M | -- | 259.3M | 255.5M | 251.3M | -- |
| Diluted Shares Outstanding | 346.5M | 333.4M | 329.8M | -- | 259.3M | 255.5M | 305.9M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $2.77B | $1.53B | $1.87B | $1.56B | $1.10B | $826.3M |
| Short-Term Investments | $1.22B | $624.5M | $689.8M | $1.40B | $587.1M | $366.4M |
| **Cash & Short-Term Investments** | $3.99B | $2.15B | $2.56B | $2.96B | $1.69B | $1.19B |
| Accounts Receivable, Net | $362.7M | -- | -- | -- | -- | -- |
| Other Current Assets | $24.33M | $21.32M | $6.56M | $6.45M | $3.78M | -- |
| **Total Current Assets** | $4.61B | $2.85B | $3.06B | $4.12B | $2.31B | $1.87B |
| Property, Plant & Equipment, Net | $88.35M | $66.79M | $61.93M | $59.89M | $46.61M | $35.81M |
| Long-Term Investments | $1.47B | $1.82B | $365.3M | $222.9M | $844.5M | $325.7M |
| Other Non-Current Assets | $119.7M | $82.40M | $83.27M | $94.76M | $96.55M | $13.14M |
| **Total Non-Current Assets** | $1.71B | $2.00B | $540.4M | $405.0M | $1.02B | $401.7M |
| **Total Assets** | $6.33B | $4.84B | $3.60B | $4.53B | $3.32B | $2.27B |
| **Total Current Liabilities** | $4.86B | $3.46B | $2.43B | $3.26B | $1.85B | $1.67B |
| Long-Term Debt | $430.1M | $299.6M | $298.8M | $298.0M | $0 | $142.5M |
| Other Non-Current Liabilities | $51.99M | $61.28M | $67.57M | $72.28M | $76.84M | $0 |
| **Total Non-Current Liabilities** | $482.1M | $360.8M | $366.4M | $370.3M | $76.84M | $157.5M |
| **Total Liabilities** | $5.34B | $3.82B | $2.80B | $3.63B | $1.93B | $1.82B |
| **Total Debt (incl. Leases)** | $498.8M | $373.8M | $379.8M | $383.0M | $91.67M | $142.5M |
| Common Stock | -- | -- | -- | -- | -- | $2.0K |
| Retained Earnings | -$3.29B | -$2.85B | -$2.88B | -$2.61B | -$2.00B | -$1.43B |
| Accumulated Other Comp. Income | $18.03M | -$1.83M | $1.31M | -$9.71M | -$3.67M | $879K |
| **Total Stockholders' Equity** | $977.6M | $1.01B | $804.0M | $890.4M | $1.39B | -$1.30B |
| Total Equity | $980.7M | $1.02B | $806.1M | $892.4M | $1.39B | -$1.30B |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $4.47B | $4.08B | $4.81B | $2.77B | $2.15B | $2.60B | $2.24B | $1.53B |
| Short-Term Investments | $3.02B | $4.48B | $1.99B | $1.22B | $887.6M | $938.1M | $751.5M | $624.5M |
| **Cash & Short-Term Investments** | $7.49B | $8.56B | $6.80B | $3.99B | $3.04B | $3.54B | $2.99B | $2.15B |
| Accounts Receivable, Net | $303.3M | $380.1M | $587.0M | $362.7M | -- | -- | -- | -- |
| Other Current Assets | $59.83M | $60.32M | $25.82M | $24.33M | $28.59M | $30.46M | $23.02M | $21.32M |
| **Total Current Assets** | $8.32B | $9.37B | $7.78B | $4.61B | $3.76B | $4.31B | $3.77B | $2.85B |
| Property, Plant & Equipment, Net | $109.3M | $101.5M | $94.19M | $88.35M | $83.42M | $77.67M | $72.00M | $66.79M |
| Long-Term Investments | $1.44B | $1.60B | $1.27B | $1.47B | $1.75B | $1.85B | $1.87B | $1.82B |
| Other Non-Current Assets | $114.1M | $122.1M | $122.7M | $119.7M | $120.6M | $116.3M | $93.58M | $82.40M |
| **Total Non-Current Assets** | $1.69B | $1.85B | $1.51B | $1.71B | $1.98B | $2.07B | $2.07B | $2.00B |
| **Total Assets** | $10.01B | $11.23B | $9.29B | $6.33B | $5.75B | $6.38B | $5.84B | $4.84B |
| **Total Current Liabilities** | $7.30B | $8.69B | $7.14B | $4.86B | $3.98B | $4.87B | $4.15B | $3.46B |
| Long-Term Debt | $432.4M | $431.6M | $430.9M | $430.1M | $686.3M | $299.9M | $299.7M | $299.6M |
| Other Non-Current Liabilities | $49.32M | $50.47M | $51.37M | $51.99M | $55.77M | $57.27M | $59.33M | $61.28M |
| **Total Non-Current Liabilities** | $481.7M | $482.1M | $482.2M | $482.1M | $742.1M | $357.2M | $359.1M | $360.8M |
| **Total Liabilities** | $7.78B | $9.17B | $7.62B | $5.34B | $4.72B | $5.22B | $4.51B | $3.82B |
| **Total Debt (incl. Leases)** | $432.4M | $431.6M | $430.9M | $498.8M | $686.3M | $299.9M | $299.7M | $373.8M |
| Retained Earnings | -$2.09B | -$2.25B | -$2.62B | -$3.29B | -$2.94B | -$2.80B | -$2.58B | -$2.85B |
| Accumulated Other Comp. Income | -$41.66M | -$8.25M | $5.00M | $18.03M | $16.39M | $13.72M | $9.60M | -$1.83M |
| **Total Stockholders' Equity** | $2.22B | $2.05B | $1.66B | $977.6M | $1.02B | $1.16B | $1.33B | $1.01B |
| Total Equity | $2.23B | $2.06B | $1.67B | $980.7M | $1.03B | $1.16B | $1.34B | $1.02B |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$442.9M | $26.12M | -$270.6M | -$609.6M | -$571.4M | -$406.8M | -$261.2M |
| Depreciation & Amortization | $28.89M | $32.15M | $30.69M | $15.28M | $14.61M | $11.29M | $6.90M |
| Stock-Based Compensation | $87.65M | $109.8M | $159.7M | $112.3M | $86.30M | $35.87M | $33.56M |
| **Operating Cash Flow** | $1.09B | $978.2M | -$272.2M | $380.3M | -$181.7M | $222.7M | -$165.4M |
| Capital Expenditure | -$36.37M | -$27.90M | -$25.58M | -$29.01M | -$25.89M | -$14.02M | -$26.00M |
| **Free Cash Flow** | $1.06B | $950.3M | -$297.7M | $351.3M | -$207.6M | $208.7M | -$191.4M |
| Purchases of Investments | -$1.01B | -$2.13B | -$837.0M | -$1.19B | -$1.81B | -$1.00B | -$877.7M |
| Sales & Maturities of Investments | $805.0M | $770.0M | $1.44B | $994.1M | $1.05B | $671.6M | $1.06B |
| **Investing Cash Flow** | -$241.1M | -$1.39B | $577.2M | -$226.5M | -$774.5M | -$344.7M | $150.5M |
| Share Repurchases | -- | -- | -- | -- | $0 | $0 | -$2.99M |
| **Financing Cash Flow** | $399.2M | $68.39M | $6.45M | $301.1M | $1.24B | $611.7M | -$2.12M |
| **Net Change in Cash** | $1.25B | -$340.9M | $311.5M | $454.9M | $282.5M | $489.7M | -$16.98M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $167.3M | $361.8M | $679.0M | -$352.4M | -$137.5M | -$228.5M | $275.5M | -$153.3M |
| Depreciation & Amortization | $6.54M | $6.03M | $7.02M | $7.88M | $7.31M | $6.97M | $6.73M | $9.23M |
| Stock-Based Compensation | $22.29M | $20.65M | $15.97M | $18.09M | $20.48M | $24.11M | $24.98M | $25.86M |
| Change in Receivables | $112.9M | $158.8M | -$224.3M | -- | -$2.74M | $46.16M | -$97.83M | -- |
| **Operating Cash Flow** | -$1.20B | $2.09B | $2.62B | $671.9M | -$964.7M | $509.1M | $878.5M | $346.8M |
| Capital Expenditure | -$11.31M | -$11.76M | -$8.79M | -$9.06M | -$9.01M | -$9.28M | -$9.03M | -$6.82M |
| **Free Cash Flow** | -$1.21B | $2.08B | $2.61B | $662.8M | -$973.7M | $499.8M | $869.5M | $340.0M |
| Purchases of Investments | $364.3M | -$4.03B | -$914.8M | -$233.2M | -$172.8M | -$271.0M | -$336.9M | -$110.5M |
| Sales & Maturities of Investments | $1.23B | $1.20B | $334.2M | $192.6M | $329.2M | $111.5M | $171.7M | $85.84M |
| **Investing Cash Flow** | $1.58B | -$2.83B | -$590.3M | -$48.71M | $150.1M | -$168.2M | -$174.2M | -$31.45M |
| **Financing Cash Flow** | $10.85M | $13.29M | -$3.60M | $8.17M | $364.0M | $22.13M | $4.87M | $3.82M |
| **Net Change in Cash** | $389.2M | -$729.0M | $2.03B | $631.4M | -$450.5M | $363.0M | $709.2M | $319.2M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -3.4% | 0.6% | -4.0% | -14.9% | -29.6% | -86.9% | -53.1% |
| **Net Profit Margin** | -3.8% | 0.3% | -4.6% | -15.3% | -31.1% | -87.9% | -53.5% |
| Return on Equity (ROE) | -45.3% | 2.5% | -33.7% | -68.1% | -41.3% | -- | -- |
| Return on Assets (ROA) | -7.0% | 0.5% | -7.5% | -13.4% | -17.2% | -17.9% | -- |
| Current Ratio | 0.95x | 0.82x | 1.26x | 1.26x | 1.24x | 1.12x | -- |
| Quick Ratio | 0.90x | 0.62x | 1.05x | 0.91x | 0.91x | 0.72x | -- |
| Debt to Equity | 0.51x | 0.37x | 0.47x | 0.43x | 0.07x | -- | -- |
| **Revenue Growth (YoY)** | +27.5% | +56.5% | +47.9% | +115.6% | +297.3% | -5.2% | -- |
| Operating Income Growth (YoY) | -792.1% | -- | -- | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -1842.5% | -- | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -1636.4% | -- | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | +11.9% | -- | -171.6% | -- | -181.6% | -- | -- |
| Free Cash Flow Growth (YoY) | +11.4% | -- | -184.7% | -- | -199.5% | -- | -- |
| 5Y Revenue / Share Growth | +182.0% | +125.3% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | 5.4% | 4.1% | 0.1% | -3.4% | -1.9% | -1.2% | 1.7% | 0.6% |
| **Net Profit Margin** | 4.9% | 3.6% | -0.3% | -3.8% | -2.2% | -1.5% | 1.2% | 0.3% |
| Return on Equity (ROE) | 38.5% | 26.8% | -2.4% | -45.3% | -23.8% | -13.9% | 9.3% | 2.5% |
| Return on Assets (ROA) | 8.5% | 4.9% | -0.4% | -7.0% | -4.2% | -2.5% | 2.1% | 0.5% |
| Current Ratio | 1.14x | 1.08x | 1.09x | 0.95x | 0.95x | 0.89x | 0.91x | 0.82x |
| Quick Ratio | 1.07x | 1.03x | 1.03x | 0.90x | 0.76x | 0.73x | 0.72x | 0.62x |
| Debt to Equity | 0.19x | 0.21x | 0.26x | 0.51x | 0.67x | 0.26x | 0.22x | 0.37x |
| **Revenue Growth (YoY)** | +72.1% | +70.4% | +52.6% | +17.3% | +23.2% | +29.0% | +42.2% | +67.1% |
| Operating Income Growth (YoY) | -- | -- | +137.0% | -- | -- | -439.9% | +60.1% | -- |
| **Net Income Growth (YoY)** | -- | -- | +146.7% | -- | -- | -506.3% | +55.2% | -- |
| EPS Growth (YoY) | -- | -- | +107.3% | -- | -- | -470.8% | +42.9% | -- |
| Operating Cash Flow Growth (YoY) | -- | +311.0% | +198.1% | +93.7% | -- | +2.4% | +38.5% | +16.8% |
| Free Cash Flow Growth (YoY) | -- | +316.3% | +200.2% | +95.0% | -- | +2.1% | +38.4% | +16.9% |

## Related Companies

[UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
